Btai analyst ratings

Author: gkto

August undefined, 2024

WebThe analyst firm set a price target for 66.00 expecting BTAI to rise to within 12 months … Web5. 0. 0. These 10 analysts have an average price target of $210.9 versus the current price of Honeywell Intl at $193.325, implying upside. Below is a summary of how these 10 analysts rated ...

Goldman Sachs Reaffirms Their Hold Rating on Bioxcel …

WebThe British American Tobacco stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human … bundaberg photography club

BTAI Stock Forecast, Price & News (BioXcel Therapeutics)

Web38 minutes ago · According to 6 analyst offering 12-month price targets in the last 3 months, Archer-Daniels Midland has an average price target of $90.83 with a high of $100.00 and a low of $85.00. WebApr 12, 2024 · BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) Director … WebAnalyst Rating / Earnings Estimates. Current Rating See More. Strong Buy. Based on 8 analysts offering recommendations. Earnings Estimates - Current Qtr 03/31/23 ... (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a commercial-stage biopharmaceutical company utilizing... BTAI: 17.28 (+1.29%) bundaberg photography

BTAI - Bioxcel Therapeutics Stock Analyst Ratings

BioXcel Therapeutics, Inc. (BTAI) - Stock Analysis

WebFind real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and … WebApr 11, 2024 · Analyst Ratings Changes BTAI has been the topic of several research reports. The Goldman Sachs Group raised their price target on shares of BioXcel Therapeutics from $16.00 to $26.00 and gave... half marathon september 2021 minnesotaWebMar 24, 2024 · According to 16 stock analysts, the average 12-month stock price forecast for BTAI stock is $ 57.03 , which predicts an increase of 211.30%. The lowest target is $ 20.2 and the highest is $ 82.95. On average, analysts rate BTAI stock as a buy. Analyst Consensus: Buy Analyst Ratings half marathons fall 2022

"WebAnalysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI), Avidity Biosciences (RNA) and Sensei Biotherapeutics (SNSE) Aug. 10, 2024 at 6:10 a.m. ET on TipRanks.com Recap:... " - Btai analyst ratings

Btai analyst ratings

BTAI Stock Price BioXcel Therapeutics Inc. Stock Quote (U.S.: …

WebMar 24, 2024 · According to 16 stock analysts, the average 12-month stock price … WebApr 12, 2024 · BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of BioXcel Therapeutics stock in a transaction dated Thursday, April 6th.The shares were sold at an average price of $17.32, for a total transaction of $1,039,200.00. The sale was disclosed in a filing with the Securities & …

Did you know?

WebThe Ratings Breakdown table uses Zacks' brokerage recommendations. These … WebView real-time BTAI stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 9 ratings: $52.10. ... Fundamental company data and analyst estimates ...

WebApr 10, 2024 · Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) have received an average rating of “Moderate Buy” from the eight analysts that are presently covering the company, Marketbeat ... WebFeb 28, 2024 · BioXcel Therapeutics Inc. research and ratings by Barron's. View BTAI …

WebBioXcel Therapeutics Inc. analyst estimates, including BTAI earnings per share … WebMar 20, 2024 · The number of analysts that have assigned BTAI a recommendation rating is 9. Out of them, 2 rate it a Hold, while 7 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged BioXcel Therapeutics Inc. (BTAI) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage …

WebMar 17, 2024 · View BTAI revenue estimates and earnings estimates, as well as in-depth …

WebBioXcel Therapeutics Stock (NASDAQ:BTAI), Analyst Ratings, Price Targets, … bundaberg photographerWebBTAI beat its sales estimates 0.00% of the time in past 12 months, while its overall … half marathons february 2023WebApr 6, 2024 · BTAI BioXcel Therapeutics, Inc.Wall St. Analysts Ratings & Price Target. … bundaberg physiotherapy centreWebApr 14, 2024 · Harmonic Inc. (NASDAQ:HLIT – Get Rating) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $15.86 and last traded at $15.80, with a volume of 786798 shares trading hands. The stock had previously closed at $15.51. Wall Street Analysts Forecast Growth A number of research firms […] bundaberg physio centreWebMar 29, 2024 · Close price at the end of the last trading day (Wednesday, 29th Mar 2024) … half marathon shirtsWebBTAI will report Q1 earnings on 05/08/2024 Actual Analyst Range Consensus 1.00 0.00 -1.00 -2.00 More Overview Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only;... half marathons fall 2023WebApr 6, 2024 · Analyst Forecast According to 16 analysts, the average rating for BTAI … half marathon sierra vista az